Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.

Lanitis T, Leipold R, Hamilton M, Rublee D, Quon P, Browne C, Cohen AT.

BMC Health Serv Res. 2017 Jan 23;17(1):74. doi: 10.1186/s12913-017-1995-8.

2.

Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study.

Yu J, Li D, Lei D, Yuan F, Pei F, Zhang H, Yu A, Wang K, Chen H, Chen L, Wu X, Tong X, Wang Y.

PLoS One. 2016 Nov 11;11(11):e0165390. doi: 10.1371/journal.pone.0165390. eCollection 2016.

3.

Familial primary antiphospholipid syndrome: A report of co-occurrence in three Malaysian family members.

Islam MA, Wong KK, Sasongko TH, Gan SH, Wong JS.

Eur J Rheumatol. 2016 Sep;3(3):139-141. Epub 2016 Feb 1.

4.

Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines.

Min SK, Kim YH, Joh JH, Kang JM, Park UJ, Kim HK, Chang JH, Park SJ, Kim JY, Bae JI, Choi SY, Kim CW, Park SI, Yim NY, Jeon YS, Yoon HK, Park KH.

Vasc Specialist Int. 2016 Sep;32(3):77-104. Epub 2016 Sep 30. Review.

5.

Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies.

Vora P, Soriano-Gabarró M, Suzart K, Persson Brobert G.

Patient Prefer Adherence. 2016 Aug 29;10:1657-65. doi: 10.2147/PPA.S112297. eCollection 2016. Review.

6.

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, Batson S.

PLoS One. 2016 Aug 3;11(8):e0160064. doi: 10.1371/journal.pone.0160064. eCollection 2016. Erratum in: PLoS One. 2016;11(9):e0163386.

7.

Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.

Wang KL, Chu PH, Lee CH, Pai PY, Lin PY, Shyu KG, Chang WT, Chiu KM, Huang CL, Lee CY, Lin YH, Wang CC, Yen HW, Yin WH, Yeh HI, Chiang CE, Lin SJ, Yeh SJ.

Acta Cardiol Sin. 2016 Jan;32(1):1-22. Review.

8.

Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism.

Stacy ZA, Call WB, Hartmann AP, Peters GL, Richter SK.

Cardiol Ther. 2016 Jun;5(1):1-18. doi: 10.1007/s40119-016-0058-2. Epub 2016 Mar 2. Review.

9.

Guidance for the treatment of deep vein thrombosis and pulmonary embolism.

Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, McBane RD, Moll S, Ansell J.

J Thromb Thrombolysis. 2016 Jan;41(1):32-67. doi: 10.1007/s11239-015-1317-0. Review. Erratum in: J Thromb Thrombolysis. 2016 Apr;41(3):548.

10.

The epidemiology of venous thromboembolism.

Heit JA, Spencer FA, White RH.

J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6. Review.

11.

Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.

Marik PE, Cavallazzi R.

PLoS One. 2015 Nov 20;10(11):e0143252. doi: 10.1371/journal.pone.0143252. eCollection 2015. Review.

12.

The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry.

Agnelli G, Gitt AK, Bauersachs R, Fronk EM, Laeis P, Mismetti P, Monreal M, Willich SN, Wolf WP, Cohen AT; PREFER in VTE investigators..

Thromb J. 2015 Oct 21;13:41. doi: 10.1186/s12959-015-0071-z. eCollection 2015.

13.

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, Pawlaczyk-Gabriel K, Džupina A, Sokurenko GY, Didenko YP, Andrei LD, Lessiani G, Visonà A; SURVET Study Investigators..

Circulation. 2015 Nov 17;132(20):1891-7. doi: 10.1161/CIRCULATIONAHA.115.016930. Epub 2015 Sep 25.

14.

Epidemiology of venous thromboembolism.

Heit JA.

Nat Rev Cardiol. 2015 Aug;12(8):464-74. doi: 10.1038/nrcardio.2015.83. Epub 2015 Jun 16. Review.

15.

Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA, Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF, Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM.

Thromb Res. 2015 Aug;136(2):341-7. doi: 10.1016/j.thromres.2015.05.020. Epub 2015 May 22.

16.

Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).

Huang W, Goldberg RJ, Cohen AT, Anderson FA, Kiefe CI, Gore JM, Spencer FA.

Thromb Res. 2015 Jun;135(6):1100-6. doi: 10.1016/j.thromres.2015.04.007. Epub 2015 Apr 11.

17.

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.

Kooiman J, van Hagen N, Iglesias Del Sol A, Planken EV, Lip GY, van der Meer FJ, Cannegieter SC, Klok FA, Huisman MV.

PLoS One. 2015 Apr 23;10(4):e0122520. doi: 10.1371/journal.pone.0122520. eCollection 2015.

18.

Ultrasound screening for deep venous thrombosis detection: a prospective evaluation of 200 plastic surgery outpatients.

Swanson E.

Plast Reconstr Surg Glob Open. 2015 Apr 7;3(3):e332. doi: 10.1097/GOX.0000000000000311. eCollection 2015 Mar.

19.

Engaging with quality improvement in anticoagulation management.

Barnes GD, Kline-Rogers E.

J Thromb Thrombolysis. 2015 Apr;39(3):403-9. doi: 10.1007/s11239-015-1184-8. Review.

20.

Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.

Kooiman J, den Exter PL, Kilicsoy I, Cannegieter SC, Eikenboom J, Huisman MV, Klok FA, Versteeg HH.

J Thromb Thrombolysis. 2015 Oct;40(3):323-30. doi: 10.1007/s11239-015-1180-z.

Supplemental Content

Support Center